Drug recall · February 3, 2021
Ketorolac Tromethamine Injection recall
Why: Presence of Particulate Matter - found in reserve sample vials at the firm.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ketorolac Tromethamine Injection, USP, 30 mg per mL, packaged in 1 mL Single Dose Vials (NDC 63323-162-00); 25 x 1 mL Single Dose Vials per tray (NDC 63323-162-01); For IM or IV use, Rx only, Fresenius Kabi, Lake Zurich, IL 60047.
- Lots / codes
Lot # 6121083, Exp 2/2021
- Quantity
- 945,425 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- December 23, 2020 · Voluntary: Firm initiated
- Classified
- January 27, 2021
- Reported
- February 3, 2021
- Ended
- June 9, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketorolac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.